Application of the defect distribution index to functional lung MRI of pediatric cystic fibrosis lung disease and controls.
Options
BORIS DOI
Date of Publication
March 10, 2025
Publication Type
Article
Division/Institute
Author
Munidasa, Samal | |
Curdy, Marion | |
Zanette, Brandon | |
Woods, Jason | |
Ratjen, Felix | |
Santyr, Giles |
Subject(s)
Series
Journal of Cystic Fibrosis
ISSN or ISBN (if monograph)
1873-5010
1569-1993
Publisher
Elsevier
Language
English
Publisher DOI
PubMed ID
40069051
Uncontrolled Keywords
Description
Introduction
Functional magnetic resonance imaging (MRI) of the lung usually assesses lung impairment as ventilation defect percentage (VDP). However, VDP only reflects the overall burden of disease and does not characterize the regional distribution (i.e. pattern) of defects. The defect distribution index (DDI) is a metric which shows quantitatively how clustered versus scattered defects are with a higher DDI indicating more clustered defects.Aim
To assess the applicability and validity of the DDI to 129Xe-MRI and PREFUL-MRI of CF lung disease.Methods
The DDI algorithm was applied to fractional ventilation maps previously acquired with 129Xe-MRI and PREFUL-MRI of 37 children with CF and 13 healthy controls.Results
The calculation of DDI was feasible for all MRI data. DDI was significantly higher in patients with CF compared to healthy controls (mean difference [95 % CI] 129Xe-MRI DDI60 %mean -1.94 [-2.86 - -1.02], p=0.0001), strongly correlated with other functional outcomes such as VDP and the lung clearance index, and decreased significantly in CF patients with pulmonary exacerbations after antibiotic treatment (e.g. 129Xe-MRI DDI60 % mean -1.03 [-0.44 - -1.63], p=0.002).Conclusion
The DDI is applicable to functional 129Xe-MRI and PREFUL-MRI data providing complementary information to VDP by assessing defect distribution rather than defect size. It shows meaningful clinimetric properties and improves with treatment. The DDI shows potential as a parameter for comprehensive monitoring of CF lung disease and treatment.
Functional magnetic resonance imaging (MRI) of the lung usually assesses lung impairment as ventilation defect percentage (VDP). However, VDP only reflects the overall burden of disease and does not characterize the regional distribution (i.e. pattern) of defects. The defect distribution index (DDI) is a metric which shows quantitatively how clustered versus scattered defects are with a higher DDI indicating more clustered defects.Aim
To assess the applicability and validity of the DDI to 129Xe-MRI and PREFUL-MRI of CF lung disease.Methods
The DDI algorithm was applied to fractional ventilation maps previously acquired with 129Xe-MRI and PREFUL-MRI of 37 children with CF and 13 healthy controls.Results
The calculation of DDI was feasible for all MRI data. DDI was significantly higher in patients with CF compared to healthy controls (mean difference [95 % CI] 129Xe-MRI DDI60 %mean -1.94 [-2.86 - -1.02], p=0.0001), strongly correlated with other functional outcomes such as VDP and the lung clearance index, and decreased significantly in CF patients with pulmonary exacerbations after antibiotic treatment (e.g. 129Xe-MRI DDI60 % mean -1.03 [-0.44 - -1.63], p=0.002).Conclusion
The DDI is applicable to functional 129Xe-MRI and PREFUL-MRI data providing complementary information to VDP by assessing defect distribution rather than defect size. It shows meaningful clinimetric properties and improves with treatment. The DDI shows potential as a parameter for comprehensive monitoring of CF lung disease and treatment.
File(s)
File | File Type | Format | Size | License | Publisher/Copright statement | Content | |
---|---|---|---|---|---|---|---|
1-s2.0-S1569199325000657-main.pdf | text | Adobe PDF | 3.05 MB | published |